Evaluation of RevA, a Fibronectin-Binding Protein of Borrelia burgdorferi, as a Potential Vaccine Candidate for Lyme Disease

Lignende værker

• Borrelia burgdorferi RevA Antigen Binds Host Fibronectin
  af: Brissette, Catherine A., et al.
  Udgivet: (2009)
• Borrelia burgdorferi RevA Significantly Affects Pathogenicity and Host Response in the Mouse Model of Lyme Disease
  af: Byram, Rebecca, et al.
  Udgivet: (2015)
• BB0347, from the Lyme Disease Spirochete Borrelia burgdorferi, Is Surface Exposed and Interacts with the CS1 Heparin-Binding Domain of Human Fibronectin
  af: Gaultney, Robert A., et al.
  Udgivet: (2013)
• The Borrelial Fibronectin-Binding Protein RevA Is an Early Antigen of Human Lyme Disease
  af: Brissette, Catherine A., et al.
  Udgivet: (2010)
• The multifaceted responses of primary human astrocytes and brain microvascular endothelial cells to the Lyme disease spirochete, Borrelia burgdorferi
  af: Brissette, Catherine A., et al.
  Udgivet: (2013)